Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Vaccine|June 30, 2009
Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis CHeiner Wedemeyer, Elisabeth Schuller, Verena Schlaphoff, et al.
Alimentary Pharmacology & Therapeutics|October 2, 2023
In severe alcohol-related hepatitis, acute kidney injury is prevalent, associated with mortality independent of liver disease severity, and can be predicted using IL-8 and micro-RNAsLuke D Tyson, Stephen Atkinson, Robert W Hunter, et al.
Gut|June 26, 2015
The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West AfricaMaud Lemoine, Yusuke Shimakawa, Shevanthi Nayagam, et al.
Ebiomedicine|November 4, 2019
CD8+T cells from patients with cirrhosis display a phenotype that may contribute to cirrhosis-associated immune dysfunctionFanny Lebossé, Cathrin Gudd, Enes Tunc, et al.
Gut|July 18, 2015
Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from The GambiaYusuke Shimakawa, Maud Lemoine, Harr Freeya Njai, et al.
The Lancet. Global Health|July 30, 2023
Clinical characteristics and outcomes of patients with cirrhosis and hepatocellular carcinoma in The Gambia, west Africa: a prospective cohort studyGibril Ndow, Erwan Vo-Quang, Yusuke Shimakawa, et al.
Gastroenterology|December 6, 2014
Blockade of PD1 and TIM3 restores innate and adaptive immunity in patients with acute alcoholic hepatitisLee J L Markwick, Antonio Riva, Jennifer M Ryan, et al.
Trials|April 13, 2021
Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trialNikhil Vergis, Rachel Phillips, Victoria Cornelius, et al.
The Lancet. Microbe|August 27, 2020
Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem studyBrian Hanley, Kikkeri N Naresh, Candice Roufosse, et al.
BMJ Open|February 5, 2026
Multiarm multistage randomised controlled trial of inflammatory signal inhibitors (MATIS) for patients hospitalised with COVID-19 pneumonia during the UK pandemicLorna Hazell, Clio Pillay, Victoria Cornelius, et al.
Pageof 12